Russell Investments Group’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-76
Closed -$375 3955
2025
Q1
$375 Hold
76
﹤0.01% 3696
2024
Q4
$223 Hold
76
﹤0.01% 3654
2024
Q3
$359 Sell
76
-2,724
-97% -$12.3K ﹤0.01% 3598
2024
Q2
$10.8K Buy
2,800
+2,724
+3,584% +$12.3K ﹤0.01% 3058
2024
Q1
$407 Sell
76
-17
-18% -$80 ﹤0.01% 3236
2023
Q4
$397 Sell
93
-38,991
-100% -$120K ﹤0.01% 3139
2023
Q3
$153K Sell
39,084
-2,105
-5% -$13.8K ﹤0.01% 2535
2023
Q2
$417K Buy
41,189
+415
+1% +$4.39K ﹤0.01% 2273
2023
Q1
$416K Buy
40,774
+8,357
+26% +$95.5K ﹤0.01% 2317
2022
Q4
$304K Buy
32,417
+32,324
+34,757% +$456K ﹤0.01% 2456
2022
Q3
$1K Hold
93
﹤0.01% 2891
2022
Q2
$1K Buy
+93
New +$1.27K ﹤0.01% 2870
2022
Q1
Sell
-1
Closed 2933
2021
Q4
$0 Buy
+1
New +$31 ﹤0.01% 3110

Other funds holding TSVT

Russell Investments Group's TSVT Position: Q2 2025 in Review

Russell Investments Group sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 76 shares — an estimated $375 sold.

Russell Investments Group first reported a position in TSVT in Q4 2021 and held it in 13 quarters. The position peaked at $417K in Q2 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Russell Investments Group reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Russell Investments Group sold 76 2seventy bio shares in Q2 2025, an estimated $375.
  • Russell Investments Group first reported a position in 2seventy bio in Q4 2021 and held it in 13 quarters.
  • Russell Investments Group's 2seventy bio position peaked at $417K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Russell Investments Group's 13F filing for Q2 2025, filed 13 Aug 2025.